Cover page
Cover page - shares | 3 Months Ended | |
May 31, 2022 | Jun. 30, 2022 | |
Entity Addresses [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | May 31, 2022 | |
Document Transition Report | false | |
Entity File Number | 001-14669 | |
Entity Registrant Name | HELEN OF TROY LIMITED | |
Entity Incorporation, State or Country Code | D0 | |
Entity Tax Identification Number | 74-2692550 | |
Entity Address, Address Line One | 1 Helen of Troy Plaza | |
Entity Address, City or Town | El Paso | |
Entity Address, State or Province | TX | |
Entity Address, Postal Zip Code | 79912 | |
City Area Code | 915 | |
Local Phone Number | 225-8000 | |
Title of 12(b) Security | Common Shares, $0.10 par value per share | |
Trading Symbol | HELE | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 23,968,464 | |
Entity Central Index Key | 0000916789 | |
Current Fiscal Year End Date | --02-28 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false | |
Other Address | ||
Entity Addresses [Line Items] | ||
Entity Address, Address Line One | Clarendon House | |
Entity Address, Address Line Two | 2 Church Street | |
Entity Address, City or Town | Hamilton | |
Entity Address, Country | BM |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | May 31, 2022 | Feb. 28, 2022 |
Assets, current: | ||
Cash and cash equivalents | $ 49,254 | $ 33,381 |
Receivables - principally trade, less allowances of $1,103 and $843 | 475,904 | 457,623 |
Inventory | 613,625 | 557,992 |
Prepaid expenses and other current assets | 25,969 | 25,712 |
Income taxes receivable | 11,747 | 5,430 |
Assets held for sale | 0 | 1,942 |
Total assets, current | 1,176,499 | 1,082,080 |
Property and equipment, net of accumulated depreciation of $167,153 and $161,006 | 281,008 | 205,378 |
Goodwill | 1,065,111 | 948,873 |
Other intangible assets, net of accumulated amortization of $154,670 and $150,309 | 567,097 | 537,846 |
Operating lease assets | 42,307 | 37,759 |
Deferred tax assets, net | 3,877 | 3,628 |
Other assets | 8,355 | 7,887 |
Total assets | 3,144,254 | 2,823,451 |
Liabilities, current: | ||
Accounts payable, principally trade | 323,119 | 308,178 |
Accrued expenses and other current liabilities | 246,968 | 271,675 |
Income taxes payable | 18,626 | 20,718 |
Long-term debt, current maturities | 14,622 | 1,884 |
Liabilities held for sale | 0 | 235 |
Total liabilities, current | 603,335 | 602,690 |
Long-term debt, excluding current maturities | 1,090,947 | 811,332 |
Lease liabilities, non-current | 47,272 | 43,745 |
Deferred tax liabilities, net | 31,087 | 21,582 |
Other liabilities, non-current | 15,191 | 16,763 |
Total liabilities | 1,787,832 | 1,496,112 |
Commitments and contingencies | ||
Stockholders' equity: | ||
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued | 0 | 0 |
Common stock, $0.10 par. Authorized 50,000,000 shares; 23,966,704 and 23,800,305 shares issued and outstanding | 2,397 | 2,380 |
Additional paid in capital | 305,154 | 303,740 |
Accumulated other comprehensive income | 3,361 | 202 |
Retained earnings | 1,045,510 | 1,021,017 |
Total stockholders' equity | 1,356,422 | 1,327,339 |
Total liabilities and stockholders' equity | $ 3,144,254 | $ 2,823,451 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | May 31, 2022 | Feb. 28, 2022 |
Statement of Financial Position [Abstract] | ||
Allowance on receivables | $ 1,103 | $ 843 |
Property and equipment, accumulated depreciation | 167,153 | 161,006 |
Other intangible assets, accumulated amortization | $ 154,670 | $ 150,309 |
Cumulative preferred stock, nonvoting, par value (in dollars per share) | $ 1 | $ 1 |
Cumulative preferred stock, non-voting, authorized shares (in shares) | 2,000,000 | 2,000,000 |
Cumulative preferred stock, non-voting, issued shares (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.10 | $ 0.10 |
Common stock, authorized shares (in shares) | 50,000,000 | 50,000,000 |
Common stock, shares issued (in shares) | 23,966,704 | 23,800,305 |
Common stock, shares outstanding (in shares) | 23,966,704 | 23,800,305 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
May 31, 2022 | May 31, 2021 | |
Income Statement [Abstract] | ||
Sales revenue, net | $ 508,078 | $ 541,223 |
Cost of goods sold | 296,907 | 320,631 |
Gross profit | 211,171 | 220,592 |
Selling, general and administrative expense (“SG&A”) | 177,230 | 155,751 |
Restructuring charges | 2 | 6 |
Operating income | 33,939 | 64,835 |
Non-operating income, net | 67 | 102 |
Interest expense | 4,373 | 2,995 |
Income before income tax | 29,633 | 61,942 |
Income tax expense | 5,038 | 4,970 |
Net income | $ 24,595 | $ 56,972 |
Earnings per share (“EPS”): | ||
Basic (in dollars per share) | $ 1.03 | $ 2.34 |
Diluted (in dollars per share) | $ 1.02 | $ 2.31 |
Weighted average shares used in computing EPS: | ||
Basic (in shares) | 23,865 | 24,349 |
Diluted (in shares) | 24,122 | 24,636 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
May 31, 2022 | May 31, 2021 | |
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 24,595 | $ 56,972 |
Other comprehensive income (loss), net of tax: | ||
Cash flow hedge activity - interest rate swaps | 2,206 | 757 |
Cash flow hedge activity - foreign currency contracts | 953 | (1,554) |
Total other comprehensive income (loss), net of tax | 3,159 | (797) |
Comprehensive income | $ 27,754 | $ 56,175 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands | Total | Common Stock | Additional Paid in Capital | Accumulated Other Comprehensive (Loss) Income | Retained Earnings |
Beginning balance (in shares) at Feb. 28, 2021 | 24,406 | ||||
Beginning balance at Feb. 28, 2021 | $ 1,239,347 | $ 2,441 | $ 283,396 | $ (11,656) | $ 965,166 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Net income | 56,972 | 56,972 | |||
Other comprehensive loss, net of tax | (797) | (797) | |||
Exercise of stock options (in shares) | 4 | ||||
Exercise of stock options | 275 | $ 0 | 275 | ||
Net issuance and settlement of restricted stock (in shares) | 177 | ||||
Issuance and settlement of restricted stock | 0 | $ 18 | (18) | ||
Issuance of common stock related to stock purchase plan (in shares) | 13 | ||||
Issuance of common stock related to stock purchase plan | 2,338 | $ 1 | 2,337 | ||
Common stock repurchased and retired (in shares) | (502) | ||||
Common stock repurchased and retired | (110,074) | $ (50) | (16,616) | (93,408) | |
Share-based compensation | 14,020 | 14,020 | |||
Ending balance (in shares) at May. 31, 2021 | 24,098 | ||||
Ending balance at May. 31, 2021 | 1,202,081 | $ 2,410 | 283,394 | (12,453) | 928,730 |
Beginning balance (in shares) at Feb. 28, 2022 | 23,800 | ||||
Beginning balance at Feb. 28, 2022 | 1,327,339 | $ 2,380 | 303,740 | 202 | 1,021,017 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Net income | 24,595 | 24,595 | |||
Other comprehensive loss, net of tax | 3,159 | 3,159 | |||
Exercise of stock options (in shares) | 8 | ||||
Exercise of stock options | 659 | 658 | |||
Net issuance and settlement of restricted stock (in shares) | 235 | ||||
Issuance and settlement of restricted stock | 0 | $ 24 | (24) | ||
Issuance of common stock related to stock purchase plan (in shares) | 13 | ||||
Issuance of common stock related to stock purchase plan | 2,275 | $ 1 | 2,274 | ||
Common stock repurchased and retired (in shares) | (89) | ||||
Common stock repurchased and retired | (18,224) | $ (9) | (18,113) | (102) | |
Share-based compensation | 16,619 | 16,619 | |||
Ending balance (in shares) at May. 31, 2022 | 23,967 | ||||
Ending balance at May. 31, 2022 | $ 1,356,422 | $ 2,397 | $ 305,154 | $ 3,361 | $ 1,045,510 |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
May 31, 2022 | May 31, 2021 | |
Cash used by operating activities: | ||
Net income | $ 24,595 | $ 56,972 |
Adjustments to reconcile net income to net cash used by operating activities: | ||
Depreciation and amortization | 10,498 | 8,713 |
Amortization of financing costs | 253 | 243 |
Non-cash operating lease expense | 2,543 | 2,027 |
Provision for credit losses | 320 | 0 |
Non-cash share-based compensation | 16,619 | 14,020 |
Gain on sale of Latin America and Caribbean Personal Care business | (1,336) | 0 |
Deferred income taxes and tax credits | 614 | (3,811) |
Changes in operating capital, net of effects of acquisitions of businesses: | ||
Receivables | (14,639) | (38,747) |
Inventory | (47,781) | (58,860) |
Prepaid expenses and other current assets | 651 | (2,414) |
Other assets and liabilities, net | (823) | (3,185) |
Accounts payable | 10,027 | (10,885) |
Accrued expenses and other current liabilities | (28,764) | (35,574) |
Accrued income taxes | (11,205) | 8,116 |
Net cash used by operating activities | (38,428) | (63,385) |
Cash used by investing activities: | ||
Capital and intangible asset expenditures | (76,202) | (4,006) |
Net payments to acquire businesses, net of cash acquired | (148,111) | 0 |
Proceeds from sale of Latin America and Caribbean Personal Care business | 1,804 | 0 |
Net cash used by investing activities | (222,509) | (4,006) |
Cash provided by financing activities: | ||
Proceeds from line of credit | 447,000 | 221,100 |
Repayment of line of credit | (153,000) | (52,100) |
Repayment of long-term debt | (1,900) | (1,900) |
Proceeds from share issuances under share-based compensation plans | 2,934 | 2,613 |
Payments for repurchases of common stock | (18,224) | (110,074) |
Net cash provided by financing activities | 276,810 | 59,639 |
Net increase (decrease) in cash and cash equivalents | 15,873 | (7,752) |
Cash and cash equivalents, beginning balance | 33,381 | 45,120 |
Cash and cash equivalents, ending balance | 49,254 | 37,368 |
Supplemental non-cash investing activity: | ||
Capital expenditures included in accounts payable | $ 12,812 | $ 0 |
Basis of Presentation and Relat
Basis of Presentation and Related Information | 3 Months Ended |
May 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation and Related Information | Note 1 - Basis of Presentation and Related Information Corporate Overview The accompanying condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly our consolidated financial position as of May 31, 2022 and February 28, 2022, and the results of our consolidated operations for the interim periods presented. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 28, 2022 (“Form 10-K”), and our other reports on file with the Securities and Exchange Commission (the “SEC”). When used in these notes, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries, which are all wholly-owned. We refer to our common shares, par value $0.10 per share, as “common stock.” References to “the FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to accounting principles generally accepted in the United States of America (the “U.S.”). References to “ASU” refer to the codification of GAAP in the Accounting Standards Updates issued by the FASB. References to “ASC” refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB. We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a leading consumer products company offering creative products and solutions for our customers through a diversified portfolio of brands. As of May 31, 2022, we operated three segments: Home & Outdoor, Health & Wellness, and Beauty. Our Home & Outdoor segment provides a broad range of innovative consumer products for home activities such as food preparation, cooking, cleaning and organization, as well as products for outdoor and on the go activities such as hydration, food storage, backpacks, and travel gear. The Health & Wellness segment provides health and wellness products including healthcare devices, thermometers, water and air filtration systems, humidifiers, and fans. Our Beauty segment provides mass and prestige market beauty appliances including hair styling appliances, grooming tools, decorative hair accessories, and prestige market liquid-based hair and personal care products. Our business is seasonal due to different calendar events, holidays and seasonal weather patterns. Our fiscal reporting period ends on the last day in February. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30th. We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico, Vietnam and the U.S. During the fourth quarter of fiscal 2020, we committed to a plan to divest certain assets within our Beauty segment's mass channel personal care business, which included liquid, powder and aerosol products under brands such as Pert, Brut, Sure and Infusium (“Personal Care”). On June 7, 2021, we completed the sale of our North America Personal Care business to HRB Brands LLC, for $44.7 million in cash and recognized a gain on the sale in SG&A totaling $0.5 million. On March 25, 2022, we completed the sale of the Latin America and Caribbean Personal Care business to HRB Brands LLC, for $1.8 million in cash and recognized a gain on the sale in SG&A totaling $1.3 million. See Note 3 for additional information. On April 22, 2022, we completed the acquisition of Recipe Products Ltd., a producer of innovative prestige hair care products for all types of curly and wavy hair under the Curlsmith brand (“Curlsmith”). The total purchase consideration was $149.7 million in cash, net of a preliminary closing net working capital adjustment and cash acquired. See Note 4 for additional information. On December 29, 2021, we completed the acquisition of Osprey Packs, Inc. (“Osprey”), a longtime U.S. leader in technical and everyday packs, for $409.3 million in cash, net of a final net working capital adjustment and cash acquired. Osprey is highly respected in the outdoor industry with a product lineup that includes a wide range of backpacks and daypacks for hiking, mountaineering, skiing, climbing, mountain biking, trail running, commuting, and school, as well as rugged adventure travel packs, wheeled luggage, and travel accessories. See Note 4 for additional information. The COVID-19 pandemic continues to disrupt certain parts of our supply chain, which in certain cases has limited our ability to fulfill demand and may limit our ability to fulfill demand in the future. Surges in demand and shifts in shopping patterns related to COVID-19, as well as other factors, have strained the global freight network, which has resulted in higher costs, less capacity, and longer lead times. During the first quarter of fiscal 2023, we were adversely impacted by COVID-19 related global supply chain disruptions and cost increases. The extent of COVID-19’s impact on the demand for certain of our product lines in the future will depend on future developments, including the continued new variants and surges in the spread of COVID-19, our continued ability to source and distribute our products, the impact of COVID-19 on capital and financial markets, and the related impact on consumer confidence and spending, all of which are uncertain and difficult to predict considering the continuously evolving landscape. Accordingly, our liquidity and financial results could be impacted in ways that we are not able to predict today. Principles of Consolidation The accompanying condensed consolidated financial statements are prepared in accordance with GAAP and include all of our subsidiaries. Our condensed consolidated financial statements are prepared in U.S. Dollars. All intercompany balances and transactions are eliminated in consolidation. The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results may differ materially from those estimates. |
New Accounting Pronouncements
New Accounting Pronouncements | 3 Months Ended |
May 31, 2022 | |
Accounting Changes and Error Corrections [Abstract] | |
New Accounting Pronouncements | Note 2 - New Accounting Pronouncements There have been no changes in the information provided in our Form 10-K. |
Assets and Liabilities Held for
Assets and Liabilities Held for Sale | 3 Months Ended |
May 31, 2022 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Assets and Liabilities Held for Sale | Note 3 - Assets and Liabilities Held for Sale During the fourth quarter of fiscal 2020, we committed to a plan to divest certain assets within our Personal Care business and accordingly, we classified the identified net assets of the disposal group as held for sale. On June 7, 2021, we completed the sale of our North America Personal Care business to HRB Brands LLC, for $44.7 million in cash and recognized a gain on the sale in SG&A totaling $0.5 million. The net assets sold included intangible assets, inventory, certain net trade receivables, fixed assets and certain accrued sales discounts and allowances relating to our North America Personal Care business. On March 25, 2022, we completed the sale of the Latin America and Caribbean Personal Care business to HRB Brands LLC, for $1.8 million in cash and recognized a gain on the sale in SG&A totaling $1.3 million. As a result of the sale, we no longer have any assets or liabilities classified as held for sale as of the end of our first quarter of fiscal 2023. The carrying amounts of the major classes of assets and liabilities for our Personal Care business that were classified as held for sale are as follows: (in thousands) February 28, 2022 Receivables, net of allowance of $23 $ 1,265 Inventory 611 Property and equipment, net of accumulated depreciation of $152 66 Assets held for sale $ 1,942 Accrued sales discounts and allowances $ 235 Liabilities held for sale $ 235 |
Acquisitions
Acquisitions | 3 Months Ended |
May 31, 2022 | |
Business Combination and Asset Acquisition [Abstract] | |
Acquisitions | Note 4 - Acquisitions Curlsmith On April 22, 2022, we completed the acquisition of Recipe Products Ltd., a producer of innovative prestige hair care products for all types of curly and wavy hair under the Curlsmith brand. Curlsmith's products are a category leader in the market for prestige haircare products for curly hair and include conditioners, shampoos and co-washes purposefully designed for the unique joys and challenges of all types of curls and textured hair. The Curlsmith brand and products were added to the Beauty segment. The total purchase consideration was $149.7 million in cash, net of a preliminary net working capital adjustment of $0.3 million and cash acquired. The acquisition was funded with cash on hand and borrowings under our existing revolving credit facility. We incurred pre-tax acquisition expenses of $2.7 million during the first quarter of fiscal 2023, which were recognized in SG&A within our condensed consolidated statement of income. We accounted for the acquisition as a purchase of a business and recorded the excess of the purchase price over the estimated fair value of the assets acquired and liabilities assumed as goodwill. The goodwill recognized is attributable primarily to expected synergies including leveraging our Beauty segment's existing marketing and sales structure, as well as our global sourcing, distribution, shared service, and international go-to-market capabilities. The goodwill is not expected to be deductible for income tax purposes. We have provisionally determined the appropriate fair values of the acquired intangible assets and completed our analysis of the economic lives of the assets acquired. We assigned $21.0 million to trade names and are amortizing over a 20 year expected life. We assigned $12.0 million to customer relationships and are amortizing over a 19.5 year expected life, based on historical attrition rates. The following table presents the preliminary estimated fair values of assets acquired and liabilities assumed at the acquisition date: (in thousands) Assets: Receivables $ 3,874 Inventory 7,890 Prepaid expenses and other current assets 119 Property and equipment 212 Goodwill 118,529 Trade names - definite 21,000 Customer relationships - definite 12,000 Deferred tax assets, net 395 Total assets 164,019 Liabilities: Accounts payable 1,335 Accrued expenses and other current liabilities 1,854 Income taxes payable 2,947 Deferred tax liabilities, net 8,187 Total liabilities 14,323 Net assets recorded $ 149,696 Both the fair value and gross contractual amount of receivables acquired was $3.9 million, as an immaterial amount is expected to be uncollectible. The impact of the acquisition of Curlsmith on our condensed consolidated statement of income for the first quarter of fiscal 2023 was as follows: April 22, 2022 (acquisition date) through May 31, 2022 (in thousands, except earnings per share data) Three Months Ended Sales revenue, net $ 3,246 Net income 439 EPS: Basic $ 0.02 Diluted $ 0.02 The following supplemental unaudited pro forma information presents our financial results as if the acquisition of Curlsmith had occurred on March 1, 2021. This supplemental pro forma information has been prepared for comparative purposes and would not necessarily indicate what may have occurred if the acquisition had been completed on March 1, 2021, and this information is not intended to be indicative of future results: Three Months Ended (in thousands, except earnings per share data) 2022 2021 Sales revenue, net $ 515,170 $ 550,857 Net income 26,508 55,104 EPS: Basic $ 1.11 $ 2.26 Diluted $ 1.10 $ 2.24 These amounts have been calculated after applying our accounting policies and adjusting the results of Curlsmith to reflect the effect of definite-lived intangible assets recognized as part of the business combination on amortization expense as if the acquisition had occurred on March 1, 2021. Osprey On December 29, 2021, we completed the acquisition of Osprey, a longtime U.S. leader in technical and everyday packs. Osprey is highly respected in the outdoor industry with a product lineup that includes a wide range of backpacks and daypacks for hiking, mountaineering, skiing, climbing, mountain biking, trail running, commuting, and school, as well as rugged adventure travel packs, wheeled luggage, and travel accessories. The Osprey brand and products were added to the Home & Outdoor segment. The total purchase consideration, net of cash acquired, was $409.3 million in cash, including the impact of a final $10.7 million favorable net working capital adjustment. The acquisition was funded with cash on hand and borrowings under our existing revolving credit facility. We incurred pre-tax acquisition-related expenses of $0.1 million during the first quarter of fiscal 2023, which were recognized in SG&A within our condensed consolidated statement of income. We accounted for the acquisition as a purchase of a business and recorded the excess of the purchase price over the estimated fair value of the assets acquired and liabilities assumed as goodwill. The goodwill recognized is attributable primarily to expected synergies including leveraging our information systems, shared service capabilities and international footprint. The goodwill is not expected to be deductible for income tax purposes. We have provisionally determined the appropriate fair values of the acquired intangible assets and completed our analysis of the economic lives of the assets acquired. We assigned $170.0 million to trade names which were determined to have an indefinite life. We assigned $22.0 million to customer relationships and are amortizing over a 4.5 year expected life, based on historical attrition rates. During the first quarter of fiscal 2023, we finalized the net working capital adjustment, which resulted in a $1.6 million reduction to the total purchase consideration and we reduced the provisional accounts payable liability by $0.7 million, both with a corresponding decrease to goodwill totaling $2.3 million. The following table presents the preliminary estimated fair values of assets acquired and liabilities assumed at the acquisition date: (in thousands) Assets: Receivables $ 11,758 Inventory 30,056 Prepaid expenses and other current assets 3,699 Income taxes receivable 4,197 Property and equipment 11,386 Goodwill 206,680 Trade names - indefinite 170,000 Customer relationships - definite 22,000 Operating lease assets 2,155 Total assets 461,931 Liabilities: Accounts payable 3,780 Accrued expenses and other current liabilities 7,345 Lease liabilities, non-current 1,719 Deferred tax liabilities, net 39,792 Total liabilities 52,636 Net assets recorded $ 409,295 |
Accrued Expenses and Other Curr
Accrued Expenses and Other Current Liabilities | 3 Months Ended |
May 31, 2022 | |
Payables and Accruals [Abstract] | |
Accrued Expenses and Other Current Liabilities | Note 5 - Accrued Expenses and Other Current Liabilities A summary of accrued expenses and other current liabilities is as follows: (in thousands) May 31, 2022 February 28, 2022 Accrued compensation, benefits and payroll taxes $ 26,635 $ 55,405 Accrued sales discounts and allowances 71,248 69,120 Accrued sales returns 29,729 33,384 Accrued advertising 58,740 55,775 Other 60,616 57,991 Total accrued expenses and other current liabilities $ 246,968 $ 271,675 |
Share-Based Compensation Plans
Share-Based Compensation Plans | 3 Months Ended |
May 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Share-Based Compensation Plans | Note 6 - Share-Based Compensation Plans As part of our compensation structure, we grant share-based compensation awards to certain employees and non-employee members of our Board of Directors during the fiscal year. These awards may be subject to attainment of certain service conditions, performance conditions and/or market conditions. During the first quarter of fiscal 2023, we granted 36,088 service condition awards (“Service Condition Awards”) with a weighted average grant date fair value of $204.11. Additionally, we granted 165,734 performance-based awards during the first quarter of fiscal 2023, of which 82,867 contained performance conditions (“Performance Condition Awards”) and 82,867 contained market conditions (“Market Condition Awards”), with weighted average grant date fair values of $204.11 and $152.91, respectively. Refer to our Form 10-K for further information on the Company's share-based compensation plans. We recorded share-based compensation expense in SG&A as follows: Three Months Ended May 31, (in thousands) 2022 2021 Stock options $ — $ — Directors stock compensation 173 160 Service Condition Awards 3,117 1,940 Performance Condition Awards 10,845 10,023 Market Condition Awards 1,910 1,129 Employee stock purchase plan 574 768 Share-based compensation expense 16,619 14,020 Less income tax benefits (1,084) (859) Share-based compensation expense, net of income tax benefits $ 15,535 $ 13,161 Unrecognized Share-Based Compensation Expense As of May 31, 2022, our total unrecognized share-based compensation for all awards was $60.1 million, which will be recognized over a weighted average amortization period of 2.3 years. The total unrecognized share-based compensation reflects an estimate of target achievement for Performance Condition Awards granted during the first quarter of fiscal 2023 and fiscal 2022, and a weighted average estimate of 150% of target achievement for Performance Condition Awards granted in fiscal 2021. |
Repurchases of Common Stock
Repurchases of Common Stock | 3 Months Ended |
May 31, 2022 | |
Equity [Abstract] | |
Repurchases of Common Stock | Note 7 - Repurchases of Common Stock In August 2021, our Board of Directors authorized the repurchase of up to $500 million of our outstanding common stock. The authorization became effective August 25, 2021, for a period of three years, and replaced our former repurchase authorization. As of May 31, 2022, our repurchase authorization allowed for the purchase of $403.8 million of common stock. Our current equity-based compensation plans include provisions that allow for the “net exercise” of share-settled awards by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option or other share-based award holders are settled by having the holder tender back to us a number of shares at fair value equal to the amounts due. Net exercises are treated as purchases and retirements of shares. The following table summarizes our share repurchase activity for the periods shown: Three Months Ended May 31, (in thousands, except share and per share data) 2022 2021 Common stock repurchased on the open market: Number of shares — 436,842 Aggregate value of shares $ — $ 95,484 Average price per share $ — $ 218.58 Common stock received in connection with share-based compensation: Number of shares 89,458 65,644 Aggregate value of shares $ 18,224 $ 14,590 Average price per share $ 203.71 $ 222.26 |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
May 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Note 8 - Commitments and Contingencies Legal Matters We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity, except as described below. On December 23, 2021, Brita LP filed a complaint against Kaz USA, Inc. and Helen of Troy Limited in the United States District Court for the Western District of Texas (the “Patent Litigation”), alleging patent infringement by the Company relating to its PUR gravity-fed water filtration systems. In the Patent Litigation, Brita LP seeks monetary damages and injunctive relief relating to the alleged infringement. Brita LP simultaneously filed a complaint with the United States International Trade Commission (“ITC”) against Kaz USA, Inc., Helen of Troy Limited and five other companies that sell water filtration systems (the “ITC Action”). The complaint in the ITC Action also alleges patent infringement by the Company with respect to a limited set of PUR gravity-fed water filtration systems. In the ITC Action, Brita LP requested the ITC to initiate an unfair import investigation relating to such filtration systems. This action seeks injunctive relief to prevent entry of PUR products (and certain other products) into the U.S. and removal of existing inventory that is already in the U.S. On January 25, 2022, the ITC instituted the investigation requested by the ITC Action. The Patent Litigation has been stayed pending resolution of the ITC Action. We intend to vigorously pursue our claims and defenses in these proceedings. However, we cannot predict the outcome of these proceedings, the amount or range of any potential loss, or when the proceedings will be resolved. Litigation is inherently unpredictable, and the resolution or disposition of these proceedings could, if adversely determined, have a material and adverse impact on our financial position and results of operations. Regulatory Matters Our operations are subject to national, state, local, and provincial jurisdictions' environmental, health and safety laws and regulations and industry-specific product certifications. Many of the products we sell are subject to product safety laws and regulations in various jurisdictions. These laws and regulations specify the maximum allowable levels of certain materials that may be contained in our products, provide statutory prohibitions against misbranded and adulterated products, establish ingredients and manufacturing procedures for certain products, specify product safety testing requirements, and set product identification, labeling and claim requirements. Additionally, some product lines within our Health & Wellness segment are subject to product identification, labeling and claim requirements, which are monitored and enforced by regulatory agencies, such as the U.S. Environmental Protection Agency (the “EPA”), U.S. Customs and Border Protection, the U.S. Food and Drug Administration, and the U.S. Consumer Product Safety Commission. During fiscal 2022, we were in discussions with the EPA regarding the compliance of packaging claims on certain of our products in the air and water filtration categories and a limited subset of humidifier products within the Health & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging compliance discussions, we voluntarily implemented a temporary stop shipment action on the impacted products as we worked with the EPA towards an expedient resolution. The EPA approved modest changes to our labeling claims on packaging of the air and water filtration impacted products, which we implemented, and subsequently resumed shipping during fiscal 2022. Our fiscal 2022 consolidated, and Health & Wellness segment’s, net sales revenue, gross profit and operating income was materially and adversely impacted by the stop shipment actions and the time needed to execute repackaging plans after changes were approved by the EPA. While we have resumed normalized levels of shipping of the affected inventory, we are still in process of repackaging our existing inventory of impacted products. Additionally, as a result of continuing dialogue with the EPA, we are executing further repackaging and relabeling plans on certain additional humidifier products and certain additional air filtration products. If we are not able to execute our repackaging plans on schedule to meet demand, our net sales revenue, gross profit and operating income could continue to be materially and adversely impacted. At this time, we are not aware of any fines or penalties related to this matter imposed against us by the EPA. While we do not anticipate material fines or penalties, there can be no assurances that such fines or penalties will not be imposed. During the first quarter of fiscal 2023, we recorded a $4.4 million charge to cost of goods sold to write-off the obsolete packaging for the affected additional humidifier products and affected additional air filtration products in our inventory on-hand and in-transit as of the end of the first quarter of fiscal 2023. We incurred additional compliance costs during the first quarter of fiscal 2023 of $7.2 million, comprised of $5.0 million of obsolete packaging, storage and other charges from vendors, which were recognized in cost of goods sold, and $2.2 million of incremental warehouse storage costs and legal fees, which were recognized in SG&A. During the first quarter of fiscal 2022, we recorded a $13.1 million charge to cost of goods sold to write-off the obsolete packaging for the affected products in our inventory on-hand and in-transit as of the end of the first quarter of fiscal 2022. We refer to these charges as “EPA compliance costs.” In addition, during the first quarter of fiscal 2023, we incurred and capitalized into inventory costs to repackage a portion of our existing inventory of the affected products and expect to continue to incur and capitalize such costs as we continue to repackage inventory. We also expect to incur additional compliance costs, which may include incremental warehouse storage costs, charges from vendors, and legal fees, among other things. Such potential incremental EPA compliance costs will be expensed as incurred and could materially and adversely impact our consolidated and Health & Wellness segment’s gross profit and operating income. In addition, our net sales revenue could be materially and adversely impacted by customer returns, an increase in sales discounts and allowances and by the potential impact of distribution losses at certain retailers. Additional impacts or more pronounced adverse impacts may arise that we are not currently aware of today. Accordingly, our business, results of operations and financial condition could be adversely and materially impacted in ways that we are not able to predict today. For additional information refer to Part I, Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” including “EPA Compliance Costs”. Weather-Related Incident |
Long-Term Debt
Long-Term Debt | 3 Months Ended |
May 31, 2022 | |
Debt Disclosure [Abstract] | |
Long-Term Debt | Note 9 - Long-Term Debt A summary of our long-term debt follows: (in thousands) May 31, 2022 February 28, 2022 Mississippi Business Finance Corporation Loan (the “MBFC Loan”) (1) $ 14,807 $ 16,707 Credit Agreement (2) 1,093,500 799,500 Subtotal 1,108,307 816,207 Unamortized prepaid financing fees (2,738) (2,991) Total long-term debt 1,105,569 813,216 Less: current maturities of long-term debt (14,622) (1,884) Long-term debt, excluding current maturities $ 1,090,947 $ 811,332 (1) The MBFC Loan is unsecured and, at May 31, 2022 and February 28, 2022, bore floating interest based on either the London Interbank Offered Rate (“LIBOR”) plus a margin of up to 2.0%, or a Base Rate plus a margin of up to 1.0%, as determined by the interest rate elected and the Net Leverage Ratio defined in the loan agreement. The weighted average interest rates on borrowings outstanding were 2.4% and 1.2% at May 31, 2022 and February 28, 2022, respectively. (2) The Credit Agreement (defined below) is unsecured and, at May 31, 2022 and February 28, 2022, bore floating interest at either the Base Rate or LIBOR, plus a margin based on the Net Leverage Ratio (as defined in the Credit Agreement) of 0% to 1.0% and 1.0% to 2.0% for Base Rate and LIBOR borrowings, respectively. These floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $125 million of the outstanding principal balance under the Credit Agreement as of both May 31, 2022 and February 28, 2022 (see Notes 10, 11, and 12 for additional information regarding interest rate swaps). The weighted average interest rates on borrowings outstanding as of May 31, 2022 and February 28, 2022 were 2.4% and 1.2%, respectively. Capitalized Interest During the first quarter of fiscal 2023, we incurred interest costs totaling $5.1 million, of which we capitalized $0.7 million as part of property and equipment in connection with the construction of a new distribution center. During the first quarter of fiscal 2022, we incurred interest costs totaling $3.0 million, of which none was capitalized. Credit Agreement We have a credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provides for an unsecured total revolving commitment of $1.25 billion and matures on March 13, 2025. On June 28, 2022, we entered into an amendment to the Credit Agreement to, among other things, replace LIBOR with Term SOFR (as defined in the Credit Agreement) as the reference interest rate. Accordingly, we are updating our interest rate swap contracts associated with our revolving borrowings to replace LIBOR with Term SOFR as the reference interest rate. In connection with the amendment, we also (i) exercised the accordion under the Credit Agreement and borrowed $250 million as term loans, and (ii) provided a notice relating to a qualified acquisition, which triggered temporary adjustments to the maximum leverage ratio as further described below. The term loans will be payable at the end of each fiscal quarter in equal installments of 0.625% of the terms loans made with the remaining balance due at the maturity date. The maturity date of the term loans is March 13, 2025, which is the same maturity date as the revolving loans under the Credit Agreement. The proceeds from the term loans were used to repay revolving loans under the Credit Agreement. We may prepay the term loans, in whole or in part, at any time without premium or penalty. Following the amendment, borrowings under the Credit Agreement bear floating interest at either the Base Rate or Term SOFR, plus a margin based on the Net Leverage Ratio (as defined in the Credit Agreement) of 0% to 1.0% and 1.0% to 2.0% for Base Rate and Term SOFR borrowings, respectively, plus a credit spread of 0.10% for Term SOFR borrowings. As a result of the notice for the qualified acquisition, the maximum leverage ratio is 4.25 to 1.00 through May 31, 2022, 4.00 to 1.00 through February 28, 2023, 3.75 to 1.00 through May 31, 2023 and 3.50 to 1.00 thereafter. As of May 31, 2022, the balance of outstanding letters of credit was $32.7 million and the amount available for revolving borrowings under our Credit Agreement was $123.8 million. After giving effect to the term loan borrowings and application of those loans to repay revolving borrowings under the Credit Agreement, the remaining amount available for revolving borrowings under our Credit Agreement would have been $373.8 million as of May 31, 2022. Debt Covenants As of May 31, 2022, we were in compliance with all covenants as defined under the terms of the Credit Agreement and our other debt agreements. |
Fair Value
Fair Value | 3 Months Ended |
May 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value | Note 10 - Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Valuation techniques under the accounting guidance related to fair value measurements are based on observable and unobservable inputs. These inputs are classified into the following hierarchy: Level 1: Quoted prices for identical assets or liabilities in active markets; Level 2: Observable inputs other than quoted prices that are directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets; quoted prices for similar or identical assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions. Our financial assets and liabilities are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable. The following table presents the carrying amount and fair value of our financial assets and liabilities measured and recorded at fair value on a recurring basis and classified as Level 2 as follows: Carrying Amount and Fair Value (in thousands) May 31, 2022 February 28, 2022 Assets: Cash equivalents (money market accounts) $ 459 $ 438 Interest rate swaps 105 — Foreign currency derivatives 4,357 2,918 Total assets $ 4,921 $ 3,356 Liabilities: Interest rate swaps $ — $ 2,781 Foreign currency derivatives 429 825 Total liabilities $ 429 $ 3,606 The carrying amounts of cash, accounts payable, accrued expenses and other current liabilities and income taxes payable approximate fair value because of the short maturity of these items. The carrying amounts of receivables approximate fair value due to the effect of the related allowance for credit losses. The carrying amount of our floating rate long-term debt approximates its fair value. We use derivatives to manage our exposure to changes in foreign currency exchange rates, which include foreign currency forward contracts and cross-currency debt swaps. In addition, we use interest rate swaps to manage our exposure to changes in interest rates. All of our derivative assets and liabilities are recorded at fair value. See Notes 11 and 12 for more information on our derivatives. |
Financial Instruments and Risk
Financial Instruments and Risk Management | 3 Months Ended |
May 31, 2022 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Financial Instruments and Risk Management | Note 11 - Financial Instruments and Risk Management Foreign Currency Risk The U.S. Dollar is the functional currency for the Company and all of its subsidiaries and is also the reporting currency for the Company. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”). Such transactions include sales, certain inventory purchases and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies. Approximately 13% and 12% of our net sales revenue was denominated in foreign currencies during the three month periods ended May 31, 2022 and 2021, respectively. These sales were primarily denominated in British Pounds, Euros, Mexican Pesos and Canadian Dollars. We make most of our inventory purchases from manufacturers in Asia and primarily use the U.S. Dollar for such purchases. In our condensed consolidated statements of income, foreign currency exchange rate gains and losses resulting from the remeasurement of foreign taxes receivable, taxes payable, deferred tax assets, and deferred tax liabilities are recognized in their respective income tax lines, and all other foreign currency exchange rate gains and losses are recognized in SG&A. During the three month periods ended May 31, 2022 and 2021, we recorded foreign currency exchange rate net gains of $0.2 million and $0.4 million, respectively, in SG&A. We mitigate certain foreign currency exchange rate risk by using forward contracts (“foreign currency contracts”) and mark-to-market cross-currency debt swaps to protect against the foreign currency exchange rate risk inherent in our transactions denominated in foreign currencies. We do not enter into any derivatives or similar instruments for trading or other speculative purposes. Our foreign currency contracts are designated as cash flow hedges and are recorded on the balance sheet at fair value with changes in fair value recorded in Other Comprehensive Income (Loss) (“OCI”) until the hedge transaction is settled, at which point amounts are reclassified from Accumulated Other Comprehensive Income (Loss) (“AOCI”) to our condensed consolidated statements of income. Derivatives for which we have not elected hedge accounting consist of our cross-currency debt swaps, and any changes in the fair value of the derivatives are recorded in our condensed consolidated statements of income. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness. Any ineffectiveness, which is not material for any period presented, is immediately recognized in our condensed consolidated statements of income. Interest Rate Risk Interest on our outstanding debt as of May 31, 2022 is based on floating interest rates. If short-term interest rates increase, we will incur higher interest expense on any future outstanding balances of floating rate debt. Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $125.0 million of the outstanding principal balance under the Credit Agreement, which totaled $1,093.5 million as of May 31, 2022. Our interest rate swaps are designated as cash flow hedges and are recorded on the balance sheet at fair value with changes in fair value recorded in OCI until the hedge transaction is settled, at which point amounts are reclassified from AOCI to our condensed consolidated statements of income. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness. Any ineffectiveness, which is not material for any period presented, is immediately recognized in our condensed consolidated statements of income. The following tables summarize the fair values of our derivative instruments as of the end of the periods presented: (in thousands) May 31, 2022 Derivatives designated as hedging instruments Hedge Final Notional Amount Prepaid Other Assets Accrued Other Forward contracts - sell Euro Cash flow 6/2023 € 33,200 $ 1,680 $ — $ 167 $ 4 Forward contracts - sell Canadian Dollars Cash flow 8/2023 $ 45,150 332 15 — — Forward contracts - sell Pounds Cash flow 6/2023 £ 25,375 2,330 — 89 1 Forward contracts - sell Australian Dollars Cash flow 12/2022 A$ 2,350 — — 25 — Forward contracts - sell Norwegian Kroner Cash flow 5/2023 kr 53,450 — — 143 — Interest rate swaps Cash flow 1/2024 $ 125,000 63 42 — — Total fair value $ 4,405 $ 57 $ 424 $ 5 (in thousands) February 28, 2022 Derivatives designated as hedging instruments Hedge Type Final Notional Amount Prepaid Other Assets Accrued Other Forward contracts - sell Euro Cash flow 2/2023 € 17,000 $ 1,224 $ — $ — $ — Forward contracts - sell Canadian Dollars Cash flow 2/2023 $ 40,000 475 — — — Forward contracts - sell Pounds Cash flow 2/2023 £ 24,000 1,219 — — — Forward contracts - sell Australian Dollars Cash flow 12/2022 A$ 5,700 — — 113 — Interest rate swaps Cash flow 1/2024 $ 125,000 — — 1,446 1,335 Subtotal 2,918 — 1,559 1,335 Derivatives not designated under hedge accounting Cross-currency debt swaps - Euro (1) 4/2022 € 6,000 — — 244 — Cross-currency debt swaps - Pounds (1) 4/2022 £ 4,500 — — 468 — Subtotal — — 712 — Total fair value $ 2,918 $ — $ 2,271 $ 1,335 (1) These cross-currency debt swaps, for which we have not elected hedge accounting, adjust the currency denomination of a portion of our outstanding debt to the Euro and British Pound, as applicable, for the notional amounts reported, creating an economic hedge against currency movements. The pre-tax effects of derivative instruments designated as cash flow hedges were as follows for the periods presented: Three Months Ended May 31, Gain (Loss) Gain (Loss) Reclassified (in thousands) 2022 2021 Location 2022 2021 Foreign currency contracts - cash flow hedges $ 2,319 $ (3,191) Sales revenue, net $ 1,196 $ (1,226) Interest rate swaps - cash flow hedges 2,206 (290) Interest expense (680) (1,284) Total $ 4,525 $ (3,481) $ 516 $ (2,510) The pre-tax effects of derivative instruments not designated under hedge accounting were as follows for the periods presented: Gain (Loss) Three Months Ended May 31, (in thousands) Location 2022 2021 Cross-currency debt swaps - principal SG&A $ 875 $ (129) Cross-currency debt swaps - interest Interest expense — (2) Total $ 875 $ (131) We expect a net gain of $4.0 million associated with foreign currency contracts and interest rate swaps currently recorded in AOCI to be reclassified into income over the next twelve months. The amount ultimately realized, however, will differ as exchange rates and interest rates change and the underlying contracts settle. See Notes 10 and 12 to these condensed consolidated financial statements for more information. Counterparty Credit Risk Financial instruments, including foreign currency contracts, cross-currency debt swaps and interest rate swaps, expose us to counterparty credit risk for non-performance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments. We believe that the risk of incurring credit losses is remote. |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Income (Loss) | 3 Months Ended |
May 31, 2022 | |
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] | |
Accumulated Other Comprehensive Income (Loss) | Note 12 - Accumulated Other Comprehensive Income (Loss) The changes in AOCI by component and related tax effects for the periods presented were as follows: (in thousands) Interest Foreign Total Balance at February 28, 2021 $ (7,576) $ (4,080) $ (11,656) Other comprehensive loss before reclassification (290) (3,191) (3,481) Amounts reclassified out of AOCI 1,284 1,226 2,510 Tax effects (237) 411 174 Other comprehensive income (loss) 757 (1,554) (797) Balance at May 31, 2021 $ (6,819) $ (5,634) $ (12,453) Balance at February 28, 2022 $ (2,126) $ 2,328 $ 202 Other comprehensive income before reclassification 2,206 2,319 4,525 Amounts reclassified out of AOCI 680 (1,196) (516) Tax effects (680) (170) (850) Other comprehensive income 2,206 953 3,159 Balance at May 31, 2022 $ 80 $ 3,281 $ 3,361 See Notes 9, 10 and 11 to these condensed consolidated financial statements for additional information regarding our cash flow hedges. |
Segment Information
Segment Information | 3 Months Ended |
May 31, 2022 | |
Segment Reporting [Abstract] | |
Segment Information | Note 13 - Segment Information The following tables summarize segment information for the periods presented: Three Months Ended May 31, 2022 (in thousands) Home & Outdoor Health & Wellness Beauty Total Sales revenue, net $ 234,263 $ 168,941 $ 104,874 $ 508,078 Restructuring charges — — 2 2 Operating income (loss) 29,793 (6,142) 10,288 33,939 Capital and intangible asset expenditures 72,731 1,629 1,842 76,202 Depreciation and amortization 4,495 2,812 3,191 10,498 Three Months Ended May 31, 2021 (in thousands) Home & Outdoor Health & Wellness Beauty Total Sales revenue, net $ 193,644 $ 204,096 $ 143,483 $ 541,223 Restructuring charges — — 6 6 Operating income 27,143 11,249 26,443 64,835 Capital and intangible asset expenditures 2,987 748 271 4,006 Depreciation and amortization 2,548 2,726 3,439 8,713 The following table presents net sales revenue by geographic region, in U.S. Dollars: Three Months Ended May 31, (in thousands) 2022 2021 U.S. sales revenue, net $ 372,177 73.3 % $ 404,846 74.8 % International sales revenue, net 135,901 26.7 % 136,377 25.2 % Total sales revenue, net $ 508,078 100.0 % $ 541,223 100.0 % |
Income Taxes
Income Taxes | 3 Months Ended |
May 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Note 14 - Income Taxes We reorganized the Company in Bermuda in 1994 and many of our foreign subsidiaries are not directly or indirectly owned by a U.S. parent. As such, a large portion of our foreign income is not subject to U.S. taxation on a permanent basis under current law. Additionally, our intellectual property is largely owned by foreign subsidiaries, resulting in proportionally higher earnings in jurisdictions with lower statutory tax rates, which decreases our overall effective tax rate. The taxable income earned in each jurisdiction, whether U.S. or foreign, is determined by the subsidiary's operating results and transfer pricing and tax regulations in the related jurisdictions. For interim periods, our income tax expense and resulting effective tax rate are based upon an estimated annual effective tax rate adjusted for the effects of items required to be treated as discrete to the period, including changes in tax laws, changes in estimated exposures for uncertain tax positions and other items. |
Earnings Per Share
Earnings Per Share | 3 Months Ended |
May 31, 2022 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | Note 15 - Earnings Per Share We compute basic earnings per share using the weighted average number of shares of common stock outstanding during the period. We compute diluted earnings per share using the weighted average number of shares of common stock outstanding plus the effect of dilutive securities. Dilutive securities at any given point in time may consist of outstanding options to purchase common stock and issued and contingently issuable unvested restricted stock units, performance stock units, restricted stock awards and performance restricted stock awards and other stock-based awards. Anti-dilutive securities are not included in the computation of diluted earnings per share under the treasury stock method. See Note 6 to these condensed consolidated financial statements for more information regarding stock-based awards. The following table presents our weighted average basic and diluted shares outstanding for the periods shown: Three Months Ended May 31, (in thousands) 2022 2021 Weighted average shares outstanding, basic 23,865 24,349 Incremental shares from share-based compensation arrangements 257 287 Weighted average shares outstanding, diluted 24,122 24,636 Anti-dilutive securities 29 — |
Basis of Presentation and Rel_2
Basis of Presentation and Related Information (Policies) | 3 Months Ended |
May 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Principles of Consolidation | Principles of Consolidation The accompanying condensed consolidated financial statements are prepared in accordance with GAAP and include all of our subsidiaries. Our condensed consolidated financial statements are prepared in U.S. Dollars. All intercompany balances and transactions are eliminated in consolidation. The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results may differ materially from those estimates. |
Assets and Liabilities Held f_2
Assets and Liabilities Held for Sale (Tables) | 3 Months Ended |
May 31, 2022 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Carrying amounts of major asset classes for Personal Care classified as held-for-sale | The carrying amounts of the major classes of assets and liabilities for our Personal Care business that were classified as held for sale are as follows: (in thousands) February 28, 2022 Receivables, net of allowance of $23 $ 1,265 Inventory 611 Property and equipment, net of accumulated depreciation of $152 66 Assets held for sale $ 1,942 Accrued sales discounts and allowances $ 235 Liabilities held for sale $ 235 |
Acquisitions (Tables)
Acquisitions (Tables) | 3 Months Ended |
May 31, 2022 | |
Business Combination and Asset Acquisition [Abstract] | |
Schedule of business acquisitions, by acquisition | The following table presents the preliminary estimated fair values of assets acquired and liabilities assumed at the acquisition date: (in thousands) Assets: Receivables $ 3,874 Inventory 7,890 Prepaid expenses and other current assets 119 Property and equipment 212 Goodwill 118,529 Trade names - definite 21,000 Customer relationships - definite 12,000 Deferred tax assets, net 395 Total assets 164,019 Liabilities: Accounts payable 1,335 Accrued expenses and other current liabilities 1,854 Income taxes payable 2,947 Deferred tax liabilities, net 8,187 Total liabilities 14,323 Net assets recorded $ 149,696 The following table presents the preliminary estimated fair values of assets acquired and liabilities assumed at the acquisition date: (in thousands) Assets: Receivables $ 11,758 Inventory 30,056 Prepaid expenses and other current assets 3,699 Income taxes receivable 4,197 Property and equipment 11,386 Goodwill 206,680 Trade names - indefinite 170,000 Customer relationships - definite 22,000 Operating lease assets 2,155 Total assets 461,931 Liabilities: Accounts payable 3,780 Accrued expenses and other current liabilities 7,345 Lease liabilities, non-current 1,719 Deferred tax liabilities, net 39,792 Total liabilities 52,636 Net assets recorded $ 409,295 |
Business acquisition, pro forma information | The impact of the acquisition of Curlsmith on our condensed consolidated statement of income for the first quarter of fiscal 2023 was as follows: April 22, 2022 (acquisition date) through May 31, 2022 (in thousands, except earnings per share data) Three Months Ended Sales revenue, net $ 3,246 Net income 439 EPS: Basic $ 0.02 Diluted $ 0.02 The following supplemental unaudited pro forma information presents our financial results as if the acquisition of Curlsmith had occurred on March 1, 2021. This supplemental pro forma information has been prepared for comparative purposes and would not necessarily indicate what may have occurred if the acquisition had been completed on March 1, 2021, and this information is not intended to be indicative of future results: Three Months Ended (in thousands, except earnings per share data) 2022 2021 Sales revenue, net $ 515,170 $ 550,857 Net income 26,508 55,104 EPS: Basic $ 1.11 $ 2.26 Diluted $ 1.10 $ 2.24 |
Accrued Expenses and Other Cu_2
Accrued Expenses and Other Current Liabilities (Tables) | 3 Months Ended |
May 31, 2022 | |
Payables and Accruals [Abstract] | |
Schedule of accrued expenses and other current liabilities | A summary of accrued expenses and other current liabilities is as follows: (in thousands) May 31, 2022 February 28, 2022 Accrued compensation, benefits and payroll taxes $ 26,635 $ 55,405 Accrued sales discounts and allowances 71,248 69,120 Accrued sales returns 29,729 33,384 Accrued advertising 58,740 55,775 Other 60,616 57,991 Total accrued expenses and other current liabilities $ 246,968 $ 271,675 |
Share-Based Compensation Plans
Share-Based Compensation Plans (Tables) | 3 Months Ended |
May 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Share-based compensation expense in SG&A | We recorded share-based compensation expense in SG&A as follows: Three Months Ended May 31, (in thousands) 2022 2021 Stock options $ — $ — Directors stock compensation 173 160 Service Condition Awards 3,117 1,940 Performance Condition Awards 10,845 10,023 Market Condition Awards 1,910 1,129 Employee stock purchase plan 574 768 Share-based compensation expense 16,619 14,020 Less income tax benefits (1,084) (859) Share-based compensation expense, net of income tax benefits $ 15,535 $ 13,161 |
Repurchases of Common Stock (Ta
Repurchases of Common Stock (Tables) | 3 Months Ended |
May 31, 2022 | |
Equity [Abstract] | |
Summary of share repurchase activity | The following table summarizes our share repurchase activity for the periods shown: Three Months Ended May 31, (in thousands, except share and per share data) 2022 2021 Common stock repurchased on the open market: Number of shares — 436,842 Aggregate value of shares $ — $ 95,484 Average price per share $ — $ 218.58 Common stock received in connection with share-based compensation: Number of shares 89,458 65,644 Aggregate value of shares $ 18,224 $ 14,590 Average price per share $ 203.71 $ 222.26 |
Long-Term Debt (Tables)
Long-Term Debt (Tables) | 3 Months Ended |
May 31, 2022 | |
Debt Disclosure [Abstract] | |
Summary of long-term debt | A summary of our long-term debt follows: (in thousands) May 31, 2022 February 28, 2022 Mississippi Business Finance Corporation Loan (the “MBFC Loan”) (1) $ 14,807 $ 16,707 Credit Agreement (2) 1,093,500 799,500 Subtotal 1,108,307 816,207 Unamortized prepaid financing fees (2,738) (2,991) Total long-term debt 1,105,569 813,216 Less: current maturities of long-term debt (14,622) (1,884) Long-term debt, excluding current maturities $ 1,090,947 $ 811,332 (1) The MBFC Loan is unsecured and, at May 31, 2022 and February 28, 2022, bore floating interest based on either the London Interbank Offered Rate (“LIBOR”) plus a margin of up to 2.0%, or a Base Rate plus a margin of up to 1.0%, as determined by the interest rate elected and the Net Leverage Ratio defined in the loan agreement. The weighted average interest rates on borrowings outstanding were 2.4% and 1.2% at May 31, 2022 and February 28, 2022, respectively. (2) The Credit Agreement (defined below) is unsecured and, at May 31, 2022 and February 28, 2022, bore floating interest at either the Base Rate or LIBOR, plus a margin based on the Net Leverage Ratio (as defined in the Credit Agreement) of 0% to 1.0% and 1.0% to 2.0% for Base Rate and LIBOR borrowings, respectively. These floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $125 million of the outstanding principal balance under the Credit Agreement as of both May 31, 2022 and February 28, 2022 (see Notes 10, 11, and 12 for additional information regarding interest rate swaps). The weighted average interest rates on borrowings outstanding as of May 31, 2022 and February 28, 2022 were 2.4% and 1.2%, respectively. |
Fair Value (Tables)
Fair Value (Tables) | 3 Months Ended |
May 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Schedule of carrying value and fair value of financial assets and liabilities recorded at fair value and measured on a recurring basis and classified as level 2 | The following table presents the carrying amount and fair value of our financial assets and liabilities measured and recorded at fair value on a recurring basis and classified as Level 2 as follows: Carrying Amount and Fair Value (in thousands) May 31, 2022 February 28, 2022 Assets: Cash equivalents (money market accounts) $ 459 $ 438 Interest rate swaps 105 — Foreign currency derivatives 4,357 2,918 Total assets $ 4,921 $ 3,356 Liabilities: Interest rate swaps $ — $ 2,781 Foreign currency derivatives 429 825 Total liabilities $ 429 $ 3,606 |
Financial Instruments and Ris_2
Financial Instruments and Risk Management (Tables) | 3 Months Ended |
May 31, 2022 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of fair values of derivative instruments | The following tables summarize the fair values of our derivative instruments as of the end of the periods presented: (in thousands) May 31, 2022 Derivatives designated as hedging instruments Hedge Final Notional Amount Prepaid Other Assets Accrued Other Forward contracts - sell Euro Cash flow 6/2023 € 33,200 $ 1,680 $ — $ 167 $ 4 Forward contracts - sell Canadian Dollars Cash flow 8/2023 $ 45,150 332 15 — — Forward contracts - sell Pounds Cash flow 6/2023 £ 25,375 2,330 — 89 1 Forward contracts - sell Australian Dollars Cash flow 12/2022 A$ 2,350 — — 25 — Forward contracts - sell Norwegian Kroner Cash flow 5/2023 kr 53,450 — — 143 — Interest rate swaps Cash flow 1/2024 $ 125,000 63 42 — — Total fair value $ 4,405 $ 57 $ 424 $ 5 (in thousands) February 28, 2022 Derivatives designated as hedging instruments Hedge Type Final Notional Amount Prepaid Other Assets Accrued Other Forward contracts - sell Euro Cash flow 2/2023 € 17,000 $ 1,224 $ — $ — $ — Forward contracts - sell Canadian Dollars Cash flow 2/2023 $ 40,000 475 — — — Forward contracts - sell Pounds Cash flow 2/2023 £ 24,000 1,219 — — — Forward contracts - sell Australian Dollars Cash flow 12/2022 A$ 5,700 — — 113 — Interest rate swaps Cash flow 1/2024 $ 125,000 — — 1,446 1,335 Subtotal 2,918 — 1,559 1,335 Derivatives not designated under hedge accounting Cross-currency debt swaps - Euro (1) 4/2022 € 6,000 — — 244 — Cross-currency debt swaps - Pounds (1) 4/2022 £ 4,500 — — 468 — Subtotal — — 712 — Total fair value $ 2,918 $ — $ 2,271 $ 1,335 (1) These cross-currency debt swaps, for which we have not elected hedge accounting, adjust the currency denomination of a portion of our outstanding debt to the Euro and British Pound, as applicable, for the notional amounts reported, creating an economic hedge against currency movements. |
Schedule of pre-tax effect of derivative instruments designated as hedges | The pre-tax effects of derivative instruments designated as cash flow hedges were as follows for the periods presented: Three Months Ended May 31, Gain (Loss) Gain (Loss) Reclassified (in thousands) 2022 2021 Location 2022 2021 Foreign currency contracts - cash flow hedges $ 2,319 $ (3,191) Sales revenue, net $ 1,196 $ (1,226) Interest rate swaps - cash flow hedges 2,206 (290) Interest expense (680) (1,284) Total $ 4,525 $ (3,481) $ 516 $ (2,510) |
Schedule of pre-tax effect of derivative instruments not designated as hedges | The pre-tax effects of derivative instruments not designated under hedge accounting were as follows for the periods presented: Gain (Loss) Three Months Ended May 31, (in thousands) Location 2022 2021 Cross-currency debt swaps - principal SG&A $ 875 $ (129) Cross-currency debt swaps - interest Interest expense — (2) Total $ 875 $ (131) |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Income (Loss) (Tables) | 3 Months Ended |
May 31, 2022 | |
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] | |
Summary of changes in accumulated other comprehensive income (loss) | The changes in AOCI by component and related tax effects for the periods presented were as follows: (in thousands) Interest Foreign Total Balance at February 28, 2021 $ (7,576) $ (4,080) $ (11,656) Other comprehensive loss before reclassification (290) (3,191) (3,481) Amounts reclassified out of AOCI 1,284 1,226 2,510 Tax effects (237) 411 174 Other comprehensive income (loss) 757 (1,554) (797) Balance at May 31, 2021 $ (6,819) $ (5,634) $ (12,453) Balance at February 28, 2022 $ (2,126) $ 2,328 $ 202 Other comprehensive income before reclassification 2,206 2,319 4,525 Amounts reclassified out of AOCI 680 (1,196) (516) Tax effects (680) (170) (850) Other comprehensive income 2,206 953 3,159 Balance at May 31, 2022 $ 80 $ 3,281 $ 3,361 |
Segment Information (Tables)
Segment Information (Tables) | 3 Months Ended |
May 31, 2022 | |
Segment Reporting [Abstract] | |
Schedule of segment information | The following tables summarize segment information for the periods presented: Three Months Ended May 31, 2022 (in thousands) Home & Outdoor Health & Wellness Beauty Total Sales revenue, net $ 234,263 $ 168,941 $ 104,874 $ 508,078 Restructuring charges — — 2 2 Operating income (loss) 29,793 (6,142) 10,288 33,939 Capital and intangible asset expenditures 72,731 1,629 1,842 76,202 Depreciation and amortization 4,495 2,812 3,191 10,498 Three Months Ended May 31, 2021 (in thousands) Home & Outdoor Health & Wellness Beauty Total Sales revenue, net $ 193,644 $ 204,096 $ 143,483 $ 541,223 Restructuring charges — — 6 6 Operating income 27,143 11,249 26,443 64,835 Capital and intangible asset expenditures 2,987 748 271 4,006 Depreciation and amortization 2,548 2,726 3,439 8,713 The following table presents net sales revenue by geographic region, in U.S. Dollars: Three Months Ended May 31, (in thousands) 2022 2021 U.S. sales revenue, net $ 372,177 73.3 % $ 404,846 74.8 % International sales revenue, net 135,901 26.7 % 136,377 25.2 % Total sales revenue, net $ 508,078 100.0 % $ 541,223 100.0 % |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 3 Months Ended |
May 31, 2022 | |
Earnings Per Share [Abstract] | |
Schedule of components of basic and diluted shares | The following table presents our weighted average basic and diluted shares outstanding for the periods shown: Three Months Ended May 31, (in thousands) 2022 2021 Weighted average shares outstanding, basic 23,865 24,349 Incremental shares from share-based compensation arrangements 257 287 Weighted average shares outstanding, diluted 24,122 24,636 Anti-dilutive securities 29 — |
Basis of Presentation and Rel_3
Basis of Presentation and Related Information (Details) $ / shares in Units, $ in Thousands | 3 Months Ended | ||||||
Apr. 22, 2022 USD ($) | Mar. 25, 2022 USD ($) | Dec. 29, 2021 USD ($) | Jun. 07, 2021 USD ($) | May 31, 2022 USD ($) segment $ / shares | May 31, 2021 USD ($) | Feb. 28, 2022 $ / shares | |
Discontinued Operations | |||||||
Common shares, par value (in dollars per share) | $ / shares | $ 0.10 | $ 0.10 | |||||
Number of segments | segment | 3 | ||||||
Gain on sale of North America Personal Care business | $ (500) | $ 1,336 | $ 0 | ||||
Proceeds from sale of personal care business | $ 44,700 | 1,804 | 0 | ||||
Net payments to acquire businesses, net of cash acquired | $ 148,111 | $ 0 | |||||
Curlsmith | |||||||
Discontinued Operations | |||||||
Net payments to acquire businesses, net of cash acquired | $ 149,700 | ||||||
Osprey Packs, Inc. | |||||||
Discontinued Operations | |||||||
Net payments to acquire businesses, net of cash acquired | $ 409,300 | ||||||
Latin America and Caribbean Personal Care Business | |||||||
Discontinued Operations | |||||||
Gain on sale of North America Personal Care business | $ (1,300) | ||||||
Proceeds from sale of personal care business | $ 1,800 |
Assets and Liabilities Held f_3
Assets and Liabilities Held for Sale - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | |||
Mar. 25, 2022 | Jun. 07, 2021 | May 31, 2022 | May 31, 2021 | |
Long Lived Assets Held-for-sale [Line Items] | ||||
Proceeds from sale of personal care business | $ 44,700 | $ 1,804 | $ 0 | |
Gain on sale of North America Personal Care business | $ (500) | $ 1,336 | $ 0 | |
Latin America and Caribbean Personal Care Business | ||||
Long Lived Assets Held-for-sale [Line Items] | ||||
Proceeds from sale of personal care business | $ 1,800 | |||
Gain on sale of North America Personal Care business | $ (1,300) |
Assets and Liabilities Held f_4
Assets and Liabilities Held for Sale - Carrying Amounts of Assets Held for Sale (Details) - USD ($) $ in Thousands | May 31, 2022 | Feb. 28, 2022 |
Long Lived Assets Held-for-sale [Line Items] | ||
Assets held for sale | $ 0 | $ 1,942 |
Liabilities held for sale | 0 | 235 |
Allowance on receivables | 1,103 | 843 |
Property and equipment, accumulated depreciation | $ 167,153 | 161,006 |
Personal Care | ||
Long Lived Assets Held-for-sale [Line Items] | ||
Assets held for sale | 1,942 | |
Liabilities held for sale | 235 | |
Allowance on receivables | 23 | |
Personal Care | Accrued sales discounts and allowances | ||
Long Lived Assets Held-for-sale [Line Items] | ||
Liabilities held for sale | 235 | |
Accounts receivable | Personal Care | ||
Long Lived Assets Held-for-sale [Line Items] | ||
Assets held for sale | 1,265 | |
Inventory | Personal Care | ||
Long Lived Assets Held-for-sale [Line Items] | ||
Assets held for sale | 611 | |
Property, plant and equipment | Personal Care | ||
Long Lived Assets Held-for-sale [Line Items] | ||
Assets held for sale | 66 | |
Property, Plant and Equipment, Held-for-Sale | Personal Care | ||
Long Lived Assets Held-for-sale [Line Items] | ||
Property and equipment, accumulated depreciation | $ 152 |
Acquisitions - Narrative (Detai
Acquisitions - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | |||
Apr. 22, 2022 | Dec. 29, 2021 | May 31, 2022 | May 31, 2021 | |
Business Acquisition [Line Items] | ||||
Net payments to acquire businesses | $ 148,111 | $ 0 | ||
Customer Relationships | ||||
Business Acquisition [Line Items] | ||||
Definite intangible assets | $ 22,000 | |||
Osprey | ||||
Business Acquisition [Line Items] | ||||
Expected life | 4 years 6 months | |||
Net working capital adjustment | $ 10,700 | |||
Acquisition related expenses | 100 | |||
Reduction to total purchase consideration | 1,600 | |||
Reduction to accounts payable acquired | 700 | |||
Reduction to goodwill | 2,300 | |||
Osprey | Trade Names | ||||
Business Acquisition [Line Items] | ||||
Trade names - indefinite | 170,000 | |||
Osprey | Customer Relationships | ||||
Business Acquisition [Line Items] | ||||
Definite intangible assets | 22,000 | |||
Curlsmith | ||||
Business Acquisition [Line Items] | ||||
Net payments to acquire businesses | $ 149,700 | |||
Net working capital adjustment | $ 300 | |||
Acquisition related expenses | $ 2,700 | |||
Curlsmith | Trade Names | ||||
Business Acquisition [Line Items] | ||||
Expected life | 20 years | |||
Up-front license fee | $ 21,000 | |||
Definite intangible assets | $ 21,000 | |||
Curlsmith | Customer Relationships | ||||
Business Acquisition [Line Items] | ||||
Expected life | 19 years 6 months | |||
Up-front license fee | $ 12,000 | |||
Definite intangible assets | $ 12,000 | |||
Osprey Packs, Inc. | ||||
Business Acquisition [Line Items] | ||||
Net payments to acquire businesses | $ 409,300 |
Acquisitions - Business Acquisi
Acquisitions - Business Acquisitions, by Acquisition (Details) - USD ($) $ in Thousands | May 31, 2022 | Apr. 22, 2022 | Feb. 28, 2022 | Dec. 29, 2021 |
Assets | ||||
Goodwill | $ 1,065,111 | $ 948,873 | ||
Liabilities [Abstract] | ||||
Income taxes payable | $ 2,947 | |||
Customer Relationships | ||||
Assets | ||||
Definite intangible assets | $ 22,000 | |||
Curlsmith | ||||
Assets | ||||
Receivables | 3,874 | |||
Inventory | 7,890 | |||
Prepaid expenses and other current assets | 119 | |||
Property and equipment | 212 | |||
Goodwill | 118,529 | |||
Deferred tax assets, net | 395 | |||
Total assets | 164,019 | |||
Liabilities [Abstract] | ||||
Accounts payable | 1,335 | |||
Accrued expenses and other current liabilities | 1,854 | |||
Deferred tax liabilities, net | 8,187 | |||
Total liabilities | 14,323 | |||
Net assets recorded | 149,696 | |||
Curlsmith | Trade Names | ||||
Assets | ||||
Definite intangible assets | 21,000 | |||
Curlsmith | Customer Relationships | ||||
Assets | ||||
Definite intangible assets | 12,000 | |||
Osprey | ||||
Assets | ||||
Receivables | 11,758 | |||
Inventory | 30,056 | |||
Prepaid expenses and other current assets | 3,699 | |||
Income taxes receivable | 4,197 | |||
Property and equipment | 11,386 | |||
Goodwill | 206,680 | |||
Operating lease assets | 2,155 | |||
Total assets | 461,931 | |||
Liabilities [Abstract] | ||||
Accounts payable | 3,780 | |||
Accrued expenses and other current liabilities | 7,345 | |||
Lease liabilities, non-current | 1,719 | |||
Deferred tax liabilities, net | $ 39,792 | |||
Total liabilities | 52,636 | |||
Net assets recorded | 409,295 | |||
Osprey | Trade Names | ||||
Assets | ||||
Trade names - indefinite | 170,000 | |||
Osprey | Customer Relationships | ||||
Assets | ||||
Definite intangible assets | $ 22,000 |
Acquisitions - Impact of the Ac
Acquisitions - Impact of the Acquisition of Curlsmith on Income (Details) - Curlsmith $ / shares in Units, $ in Thousands | 3 Months Ended |
May 31, 2022 USD ($) $ / shares | |
Business Acquisition [Line Items] | |
Sales revenue, net | $ | $ 3,246 |
Net income | $ | $ 439 |
EPS: | |
Basic (in dollars per share) | $ / shares | $ 0.02 |
Diluted (in dollars per share) | $ / shares | $ 0.02 |
Acquisitions - Pro Forma Inform
Acquisitions - Pro Forma Information (Details) - Curlsmith - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
May 31, 2022 | May 31, 2021 | |
Business Acquisition [Line Items] | ||
Sales revenue, net | $ 515,170 | $ 550,857 |
Net income | $ 26,508 | $ 55,104 |
EPS: | ||
Basic (in dollars per share) | $ 1.11 | $ 2.26 |
Diluted (in dollars per share) | $ 1.10 | $ 2.24 |
Accrued Expenses and Other Cu_3
Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands | May 31, 2022 | Feb. 28, 2022 |
Payables and Accruals [Abstract] | ||
Accrued compensation, benefits and payroll taxes | $ 26,635 | $ 55,405 |
Accrued sales discounts and allowances | 71,248 | 69,120 |
Accrued sales returns | 29,729 | 33,384 |
Accrued advertising | 58,740 | 55,775 |
Other | 60,616 | 57,991 |
Accrued expenses and other current liabilities | $ 246,968 | $ 271,675 |
Share-Based Compensation Plan_2
Share-Based Compensation Plans - Narrative (Details) $ / shares in Units, $ in Millions | 3 Months Ended |
May 31, 2022 USD ($) $ / shares shares | |
Share-based compensation plans | |
Expected recognition period for unrecognized share-based compensation | 2 years 3 months 18 days |
Target achievement for Performance Condition Awards, as a percentage | 150% |
Restricted Stock | |
Share-based compensation plans | |
Number of awards granted (in shares) | 165,734 |
Unrecognized share-based compensation | $ | $ 60.1 |
Service Condition Awards | |
Share-based compensation plans | |
Number of awards granted (in shares) | 36,088 |
Grant date fair value of shares granted in period (in dollars per share) | $ / shares | $ 204.11 |
Market Condition Awards | |
Share-based compensation plans | |
Number of awards granted (in shares) | 82,867 |
Grant date fair value of shares granted in period (in dollars per share) | $ / shares | $ 152.91 |
Performance Condition Awards | |
Share-based compensation plans | |
Number of awards granted (in shares) | 82,867 |
Grant date fair value of shares granted in period (in dollars per share) | $ / shares | $ 204.11 |
Share-Based Compensation Plan_3
Share-Based Compensation Plans - Share-Based Compensation Expense in SG&A (Details) - USD ($) $ in Thousands | 3 Months Ended | |
May 31, 2022 | May 31, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense, net of income tax benefits | $ 15,535 | $ 13,161 |
SG&A | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | 16,619 | 14,020 |
Less income tax benefits | (1,084) | (859) |
Stock options | SG&A | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | 0 | 0 |
Service Condition Awards | SG&A | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | 3,117 | 1,940 |
Performance Condition Awards | SG&A | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | 10,845 | 10,023 |
Market Condition Awards | SG&A | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | 1,910 | 1,129 |
Employee stock purchase plan | SG&A | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | 574 | 768 |
Directors stock compensation | SG&A | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | $ 173 | $ 160 |
Repurchases of Common Stock - N
Repurchases of Common Stock - Narrative (Details) - USD ($) | 1 Months Ended | |
Aug. 31, 2021 | May 31, 2022 | |
Equity [Abstract] | ||
Amount of shares authorized for purchase | $ 500,000,000 | |
Period for stock repurchase | 3 years | |
Remaining share repurchase amount | $ 403,800,000 |
Repurchases of Common Stock - S
Repurchases of Common Stock - Summary of Share Repurchase Activity (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
May 31, 2022 | May 31, 2021 | |
Repurchase of common stock | ||
Aggregate value of shares | $ 18,224 | $ 110,074 |
Stock Compensation Plan | ||
Repurchase of common stock | ||
Number of shares (in shares) | 89,458 | 65,644 |
Aggregate value of shares | $ 18,224 | $ 14,590 |
Average price per share (in dollars per share) | $ 203.71 | $ 222.26 |
Open Market | ||
Repurchase of common stock | ||
Number of shares (in shares) | 0 | 436,842 |
Aggregate value of shares | $ 0 | $ 95,484 |
Average price per share (in dollars per share) | $ 0 | $ 218.58 |
Commitments and Contingencies (
Commitments and Contingencies (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 30, 2022 | May 31, 2022 | May 31, 2021 | |
Weather-Related Incident | |||
Commitments and contingencies | |||
Weather related inventory write-down | $ 34,400 | ||
Probable insurance recoveries | 34,400 | ||
Health & Wellness | |||
Commitments and contingencies | |||
Charge to write off obsolete packaging | $ 7,200 | ||
Health & Wellness | Weather-Related Incident | |||
Commitments and contingencies | |||
Weather related inventory write-down | 29,900 | ||
Health & Wellness | SG&A | |||
Commitments and contingencies | |||
Charge to write off obsolete packaging | 2,200 | ||
Health & Wellness | Cost of Sales | |||
Commitments and contingencies | |||
Charge to write off obsolete packaging | 5,000 | ||
Health & Wellness | EPA Remediation Costs | |||
Commitments and contingencies | |||
Charge to write off obsolete packaging | $ 4,400 | $ 13,100 | |
Beauty | Weather-Related Incident | |||
Commitments and contingencies | |||
Weather related inventory write-down | $ 4,500 |
Long-Term Debt - Schedule (Deta
Long-Term Debt - Schedule (Details) - USD ($) $ in Thousands | 3 Months Ended | |
May 31, 2022 | Feb. 28, 2022 | |
Long-term debt | ||
Aggregate principal balance | $ 1,108,307 | $ 816,207 |
Unamortized prepaid financing fees | (2,738) | (2,991) |
Total long-term debt | 1,105,569 | 813,216 |
Less: current maturities of long-term debt | (14,622) | (1,884) |
Long-term debt, excluding current maturities | 1,090,947 | 811,332 |
MBFC loan | ||
Long-term debt | ||
Aggregate principal balance | $ 14,807 | $ 16,707 |
Weighted average effective interest rate | 2.40% | 1.20% |
MBFC loan | LIBOR | ||
Long-term debt | ||
Interest rate | 2% | |
MBFC loan | Base rate | ||
Long-term debt | ||
Interest rate | 1% | |
Credit agreement | ||
Long-term debt | ||
Aggregate principal balance | $ 1,093,500 | $ 799,500 |
Weighted average effective interest rate | 2.40% | 1.20% |
Fixed rate debt | $ 125,000 | |
Credit agreement | Minimum | LIBOR | ||
Long-term debt | ||
Interest rate | 1% | |
Credit agreement | Minimum | Base rate | ||
Long-term debt | ||
Interest rate | 0% | |
Credit agreement | Maximum | LIBOR | ||
Long-term debt | ||
Interest rate | 2% | |
Credit agreement | Maximum | Base rate | ||
Long-term debt | ||
Interest rate | 1% |
Long-Term Debt - Narrative (Det
Long-Term Debt - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Jun. 28, 2022 | May 31, 2022 | May 31, 2021 | |
Debt Instrument [Line Items] | |||
Interest costs incurred | $ 5,100 | $ 3,000 | |
Interest costs capitalized | 700 | $ 0 | |
Revolving loan | |||
Debt Instrument [Line Items] | |||
Maximum revolving commitment | 1,250,000 | ||
Credit agreement | |||
Debt Instrument [Line Items] | |||
Amount available for borrowings | $ 373,800 | ||
Credit agreement | Subsequent Event | |||
Debt Instrument [Line Items] | |||
Percent of principal due quarterly | 0.625% | ||
Credit agreement | Minimum | Base rate | |||
Debt Instrument [Line Items] | |||
Interest rate | 0% | ||
Credit agreement | Minimum | Base rate | Subsequent Event | |||
Debt Instrument [Line Items] | |||
Interest rate | 0% | ||
Credit agreement | Maximum | Base rate | |||
Debt Instrument [Line Items] | |||
Interest rate | 1% | ||
Credit agreement | Maximum | Base rate | Subsequent Event | |||
Debt Instrument [Line Items] | |||
Interest rate | 1% | ||
Credit agreement | Accordion Feature | Subsequent Event | |||
Debt Instrument [Line Items] | |||
Exercise of accordion agreement | $ 250,000 | ||
Credit agreement | Term Loan | Through May 31, 2022 | Subsequent Event | |||
Debt Instrument [Line Items] | |||
Maximum net leverage ratio | 4.25 | ||
Credit agreement | Term Loan | June 1, 2022 through February 28, 2023 | Subsequent Event | |||
Debt Instrument [Line Items] | |||
Maximum net leverage ratio | 4 | ||
Credit agreement | Term Loan | March 1, 2023 through May 31, 2023 | Subsequent Event | |||
Debt Instrument [Line Items] | |||
Maximum net leverage ratio | 3.75 | ||
Credit agreement | Term Loan | Thereafter | Subsequent Event | |||
Debt Instrument [Line Items] | |||
Maximum net leverage ratio | 3.50 | ||
Credit agreement | Term Loan | SOFR | Subsequent Event | |||
Debt Instrument [Line Items] | |||
Interest rate | 0.10% | ||
Credit agreement | Term Loan | Minimum | SOFR | Subsequent Event | |||
Debt Instrument [Line Items] | |||
Interest rate | 1% | ||
Credit agreement | Term Loan | Maximum | SOFR | Subsequent Event | |||
Debt Instrument [Line Items] | |||
Interest rate | 2% | ||
Credit agreement | Letter of credit | |||
Debt Instrument [Line Items] | |||
Amount outstanding, letters of credit | $ 32,700 | ||
MBFC loan | |||
Debt Instrument [Line Items] | |||
Amount available for borrowings | $ 123,800 | ||
MBFC loan | Base rate | |||
Debt Instrument [Line Items] | |||
Interest rate | 1% |
Fair Value (Details)
Fair Value (Details) - Recurring - Fair Values - Fair Value, Inputs, Level 2 - USD ($) $ in Thousands | May 31, 2022 | Feb. 28, 2022 |
Assets: | ||
Total assets | $ 4,921 | $ 3,356 |
Liabilities: | ||
Total liabilities | 429 | 3,606 |
Interest rate swaps | ||
Assets: | ||
Foreign currency derivatives | 105 | 0 |
Liabilities: | ||
Derivative liabilities | 0 | 2,781 |
Foreign currency derivatives | ||
Assets: | ||
Foreign currency derivatives | 4,357 | 2,918 |
Liabilities: | ||
Derivative liabilities | 429 | 825 |
Money market funds | ||
Assets: | ||
Cash equivalents (money market accounts) | $ 459 | $ 438 |
Financial Instruments and Ris_3
Financial Instruments and Risk Management - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
May 31, 2022 | May 31, 2021 | Feb. 28, 2022 | |
Foreign Currency Risk and Currency Exchange Uncertainties | |||
Aggregate principal balance | $ 1,108,307 | $ 816,207 | |
Foreign currency derivatives | Cash flow hedges | |||
Foreign Currency Risk and Currency Exchange Uncertainties | |||
Net gain reported in AOCI to be reclassified | $ (4,000) | ||
Period of reclassification to AOCI | 12 months | ||
Credit agreement | |||
Foreign Currency Risk and Currency Exchange Uncertainties | |||
Fixed rate debt | $ 125,000 | ||
Aggregate principal balance | 1,093,500 | $ 799,500 | |
SG&A | |||
Foreign Currency Risk and Currency Exchange Uncertainties | |||
Net foreign exchange gains (losses), including the impact of currency hedges and currency swaps | $ 200 | $ 400 | |
Net sales revenue | Geographic concentration | International operations - transactions denominated in foreign currencies | |||
Foreign Currency Risk and Currency Exchange Uncertainties | |||
Concentration risk percentage | 13% | 12% |
Financial Instruments and Ris_4
Financial Instruments and Risk Management - Derivative FV (Details) € in Thousands, £ in Thousands, kr in Thousands, $ in Thousands, $ in Thousands, $ in Thousands | May 31, 2022 EUR (€) | May 31, 2022 USD ($) | May 31, 2022 CAD ($) | May 31, 2022 GBP (£) | May 31, 2022 AUD ($) | May 31, 2022 NOK (kr) | Feb. 28, 2022 EUR (€) | Feb. 28, 2022 USD ($) | Feb. 28, 2022 CAD ($) | Feb. 28, 2022 GBP (£) | Feb. 28, 2022 AUD ($) |
Prepaid Expenses and Other Current Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | $ 4,405 | $ 2,918 | |||||||||
Other Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 57 | 0 | |||||||||
Accrued Expenses and Other Current Liabilities | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 424 | 2,271 | |||||||||
Other Liabilities, Non- current | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 5 | 1,335 | |||||||||
Derivatives designated as hedging instruments | Prepaid Expenses and Other Current Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 2,918 | ||||||||||
Derivatives designated as hedging instruments | Other Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 0 | ||||||||||
Derivatives designated as hedging instruments | Accrued Expenses and Other Current Liabilities | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 1,559 | ||||||||||
Derivatives designated as hedging instruments | Other Liabilities, Non- current | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 1,335 | ||||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Euros | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Notional Amount | € | € 33,200 | € 17,000 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Euros | Prepaid Expenses and Other Current Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 1,680 | 1,224 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Euros | Other Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 0 | 0 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Euros | Accrued Expenses and Other Current Liabilities | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 167 | 0 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Euros | Other Liabilities, Non- current | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 4 | 0 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Canadian Dollars | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Notional Amount | $ 45,150 | $ 40,000 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Canadian Dollars | Prepaid Expenses and Other Current Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 332 | 475 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Canadian Dollars | Other Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 15 | 0 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Canadian Dollars | Accrued Expenses and Other Current Liabilities | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 0 | 0 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Canadian Dollars | Other Liabilities, Non- current | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 0 | 0 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Pounds | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Notional Amount | £ | £ 25,375 | £ 24,000 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Pounds | Prepaid Expenses and Other Current Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 2,330 | 1,219 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Pounds | Other Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 0 | 0 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Pounds | Accrued Expenses and Other Current Liabilities | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 89 | 0 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Pounds | Other Liabilities, Non- current | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 1 | 0 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Australian Dollars | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Notional Amount | $ 2,350 | $ 5,700 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Australian Dollars | Prepaid Expenses and Other Current Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 0 | 0 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Australian Dollars | Other Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 0 | 0 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Australian Dollars | Accrued Expenses and Other Current Liabilities | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 25 | 113 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Australian Dollars | Other Liabilities, Non- current | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 0 | 0 | |||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Norwegian Kroner | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Notional Amount | kr | kr 53,450 | ||||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Norwegian Kroner | Prepaid Expenses and Other Current Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 0 | ||||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Norwegian Kroner | Other Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 0 | ||||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Norwegian Kroner | Accrued Expenses and Other Current Liabilities | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 143 | ||||||||||
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Norwegian Kroner | Other Liabilities, Non- current | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 0 | ||||||||||
Derivatives designated as hedging instruments | Interest rate swaps | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Notional Amount | 125,000 | 125,000 | |||||||||
Derivatives designated as hedging instruments | Interest rate swaps | Prepaid Expenses and Other Current Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 63 | 0 | |||||||||
Derivatives designated as hedging instruments | Interest rate swaps | Other Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 42 | 0 | |||||||||
Derivatives designated as hedging instruments | Interest rate swaps | Accrued Expenses and Other Current Liabilities | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 0 | 1,446 | |||||||||
Derivatives designated as hedging instruments | Interest rate swaps | Other Liabilities, Non- current | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | $ 0 | 1,335 | |||||||||
Derivatives not designated under hedge accounting | Prepaid Expenses and Other Current Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 0 | ||||||||||
Derivatives not designated under hedge accounting | Other Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 0 | ||||||||||
Derivatives not designated under hedge accounting | Accrued Expenses and Other Current Liabilities | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 712 | ||||||||||
Derivatives not designated under hedge accounting | Other Liabilities, Non- current | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 0 | ||||||||||
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Notional Amount | € | € 6,000 | ||||||||||
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Prepaid Expenses and Other Current Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 0 | ||||||||||
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Other Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 0 | ||||||||||
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Accrued Expenses and Other Current Liabilities | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 244 | ||||||||||
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Other Liabilities, Non- current | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 0 | ||||||||||
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Notional Amount | £ | £ 4,500 | ||||||||||
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Prepaid Expenses and Other Current Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 0 | ||||||||||
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Other Assets | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative assets | 0 | ||||||||||
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Accrued Expenses and Other Current Liabilities | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | 468 | ||||||||||
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Other Liabilities, Non- current | |||||||||||
Fair values of derivative instruments in the consolidated balance sheet | |||||||||||
Derivative liabilities | $ 0 |
Financial Instruments and Ris_5
Financial Instruments and Risk Management - Derivative Tax Effect (Details) - USD ($) $ in Thousands | 3 Months Ended | |
May 31, 2022 | May 31, 2021 | |
Pre-tax effect of derivative instruments | ||
Gain (Loss) Recognized in AOCI | $ 4,525 | $ (3,481) |
Gain (Loss) Reclassified from AOCI into Income | 516 | (2,510) |
Gain (Loss) Recognized in Income | 875 | (131) |
Foreign currency derivatives | Cash flow hedges | ||
Pre-tax effect of derivative instruments | ||
Gain (Loss) Recognized in AOCI | 2,319 | (3,191) |
Foreign currency derivatives | Cash flow hedges | SG&A | ||
Pre-tax effect of derivative instruments | ||
Gain (Loss) Reclassified from AOCI into Income | 1,196 | (1,226) |
Interest rate swaps | Cash flow hedges | ||
Pre-tax effect of derivative instruments | ||
Gain (Loss) Recognized in AOCI | 2,206 | (290) |
Interest rate swaps | Cash flow hedges | Interest expense | ||
Pre-tax effect of derivative instruments | ||
Gain (Loss) Reclassified from AOCI into Income | (680) | (1,284) |
Cross currency debt swaps | SG&A | ||
Pre-tax effect of derivative instruments | ||
Gain (Loss) Recognized in Income | 875 | (129) |
Cross currency debt swaps | Interest expense | ||
Pre-tax effect of derivative instruments | ||
Gain (Loss) Recognized in Income | $ 0 | $ (2) |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
May 31, 2022 | May 31, 2021 | |
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning balance | $ 1,327,339 | $ 1,239,347 |
Other comprehensive income before reclassification | 4,525 | (3,481) |
Amounts reclassified out of AOCI | (516) | 2,510 |
Tax effects | (850) | 174 |
Total other comprehensive income (loss), net of tax | 3,159 | (797) |
Ending balance | 1,356,422 | 1,202,081 |
Interest Rate Swaps | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning balance | (2,126) | (7,576) |
Other comprehensive income before reclassification | 2,206 | (290) |
Amounts reclassified out of AOCI | 680 | 1,284 |
Tax effects | (680) | (237) |
Total other comprehensive income (loss), net of tax | 2,206 | 757 |
Ending balance | 80 | (6,819) |
Foreign Currency Contracts | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning balance | 2,328 | (4,080) |
Other comprehensive income before reclassification | 2,319 | (3,191) |
Amounts reclassified out of AOCI | (1,196) | 1,226 |
Tax effects | (170) | 411 |
Total other comprehensive income (loss), net of tax | 953 | (1,554) |
Ending balance | 3,281 | (5,634) |
Total | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning balance | 202 | (11,656) |
Total other comprehensive income (loss), net of tax | 3,159 | (797) |
Ending balance | $ 3,361 | $ (12,453) |
Segment Information - Segment I
Segment Information - Segment Information by Segment (Details) - USD ($) $ in Thousands | 3 Months Ended | |
May 31, 2022 | May 31, 2021 | |
Segment information | ||
Sales revenue, net | $ 508,078 | $ 541,223 |
Restructuring charges | 2 | 6 |
Operating income (loss) | 33,939 | 64,835 |
Capital and intangible asset expenditures | 76,202 | 4,006 |
Depreciation and amortization | 10,498 | 8,713 |
Home & Outdoor | ||
Segment information | ||
Sales revenue, net | 234,263 | 193,644 |
Restructuring charges | 0 | 0 |
Operating income (loss) | 29,793 | 27,143 |
Capital and intangible asset expenditures | 72,731 | 2,987 |
Depreciation and amortization | 4,495 | 2,548 |
Health & Wellness | ||
Segment information | ||
Sales revenue, net | 168,941 | 204,096 |
Restructuring charges | 0 | 0 |
Operating income (loss) | (6,142) | 11,249 |
Capital and intangible asset expenditures | 1,629 | 748 |
Depreciation and amortization | 2,812 | 2,726 |
Beauty | ||
Segment information | ||
Sales revenue, net | 104,874 | 143,483 |
Restructuring charges | 2 | 6 |
Operating income (loss) | 10,288 | 26,443 |
Capital and intangible asset expenditures | 1,842 | 271 |
Depreciation and amortization | $ 3,191 | $ 3,439 |
Segment Information - Revenue b
Segment Information - Revenue by Domestic and International (Details) - USD ($) $ in Thousands | 3 Months Ended | |
May 31, 2022 | May 31, 2021 | |
Segment information | ||
Sales revenue, net | $ 508,078 | $ 541,223 |
U.S. sales revenue, net | ||
Segment information | ||
Sales revenue, net | 372,177 | 404,846 |
International sales revenue, net | ||
Segment information | ||
Sales revenue, net | $ 135,901 | $ 136,377 |
Revenue from Contract with Customer Benchmark | Geographic concentration | ||
Segment information | ||
Concentration risk percentage | 100% | 100% |
Revenue from Contract with Customer Benchmark | Geographic concentration | U.S. sales revenue, net | ||
Segment information | ||
Concentration risk percentage | 73.30% | 74.80% |
Revenue from Contract with Customer Benchmark | Geographic concentration | International sales revenue, net | ||
Segment information | ||
Concentration risk percentage | 26.70% | 25.20% |
Income Taxes (Details)
Income Taxes (Details) | 3 Months Ended | |
May 31, 2022 | May 31, 2021 | |
Income Tax Disclosure [Abstract] | ||
Income tax expense (benefit) as a percent of income before income taxes | 17% | 8% |
Earnings per Share (Details)
Earnings per Share (Details) - shares shares in Thousands | 3 Months Ended | |
May 31, 2022 | May 31, 2021 | |
Weighted average diluted securities | ||
Weighted average shares outstanding, basic (in shares) | 23,865 | 24,349 |
Incremental shares from share-based payment arrangements (in shares) | 257 | 287 |
Weighted average shares outstanding, diluted (in shares) | 24,122 | 24,636 |
Anti-dilutive securities | ||
Weighted average diluted securities | ||
Antidilutive securities (in shares) | 29 | 0 |